Cytosorbents Corporation
Method of treating inflammation
Last updated:
Abstract:
The present invention concerns methods of administering a therapeutically effective dose of a sorbent for an inflammatory mediator to a patient where the inflammatory mediator is one or more of enzymes, cytokines, prostaglandins, eicosanoids, leukotrienes, kinins, complement, coagulation factors, endotoxins, enterotoxins, lipopolysaccharide, cell fragments, bile salts, fatty acids, phospholipids, interferon and immunomodulatory antibodies, biologics or drugs.
Status:
Grant
Type:
Utility
Filling date:
29 May 2019
Issue date:
16 Mar 2021